ArticleLife (Basel, Switzerland)2022

Protocol of an Exploratory Single-Arm Study to Evaluate the Safety and Immunogenicity of KD-414 as a Booster Vaccine for SARS-CoV-2 in Healthy Adults (KAPIVARA).

Yuriko Terayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.